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In Brief
Following 65 patientswho had undergone
allogeneic transplantation with either
bone marrow or mobilized peripheral
blood stem cells (PBSCs), Ryde´n and
colleagues reveal that bone marrow-
derived progenitors contribute 10% to
the subcutaneous fat cell population. BM/
PBSC contribution, via adipocyte
differentiation or cell fusion, is
significantly increased in obese
individuals.
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Because human white adipocytes display a high
turnover throughout adulthood, a continuous supply
of precursor cells is required to maintain adipo-
genesis. Bone marrow (BM)-derived progenitor cells
may contribute to mammalian adipogenesis; how-
ever, results in animal models are conflicting. Here
we demonstrate in 65 subjects who underwent allo-
geneic BM or peripheral blood stem cell (PBSC)
transplantation that, over the entire lifespan, BM/
PBSC-derived progenitor cells contribute 10% to
the subcutaneous adipocyte population. While this
is independent of gender, age, and different trans-
plantation-related parameters, body fat mass exerts
a strong influence, with up to 2.5-fold increased
donor cell contribution in obese individuals. Exome
and whole-genome sequencing of single adipocytes
suggests that BM/PBSC-derived progenitors con-
tribute to adipose tissue via both differentiation and
cell fusion. Thus, at least in the setting of transplanta-
tion, BM serves as a reservoir for adipocyte progen-
itors, particularly in obese subjects.
INTRODUCTION
Adipocytes are regarded to be post-mitotic cells, with an
average lifespan in adult humans estimated to be 10 years
(Spalding et al., 2008). Fat cell turnover is determined by the
balance between adipogenesis and programmed cell death
and requires a continuous supply of adipocyte precursor cells
throughout life. Turnover rates are not influenced by fat mass,
but because obese individuals have twice as many fat cells as
lean subjects, the generation of new adipocytes (production
rate) is doubled in obesity (Spalding et al., 2008).
White adipocytes develop from progenitor cells within white
adipose tissue (WAT) whose precise origin remains uncharacter-408 Cell Metabolism 22, 408–417, September 1, 2015 ª2015 Elsevieized (Berry et al., 2014). Multipotent stem cells are present in the
perivascular stroma of WAT (Crisan et al., 2008; Lin et al., 2008;
Zannettino et al., 2008), and recent data in murine models sug-
gest that adipocytes arise from different progenitor populations
during development, in adulthood, and upon obesity (Jeffery
et al., 2015; Jiang et al., 2014). However, it remains unclear
whether adipocyte precursors derive solely from permanent res-
idents or whether cells from other tissues may also migrate into
WAT and undergo adipogenic differentiation. In particular, the in-
terest has been focused on the possible contribution of bone
marrow (BM) to mammalian adipogenesis in different murine
models. Transplantation of green fluorescent protein-expressing
(GFP+) BM-derived cells into mice generated a small population
(2%–7%) of GFP+ adipocytes that increased (up to 8%–25%) in
the presence of pro-adipogenic compounds or a high-fat diet
(Crossno et al., 2006). The contribution of BM was gender,
depot, and age dependent, occasionally reaching a maximum
of 25% in the gonadal WAT of individual female mice (Majka
et al., 2010). In contrast, other studies reported no significant
contribution of BM-derived cells to either rat (Tomiyama et al.,
2008) or mouse (Koh et al., 2007) WAT, resulting in uncertainty
as to the precise contribution of BM-derived progenitor cells to
adipogenesis in rodentmodels. It is therefore important to estab-
lish the role of BM in human adipogenesis.
The ability of BM-derived cells to generate non-hematopoietic
lineages has been intensely debated for over a decade (Ander-
son et al., 2001; Krause et al., 2001; Wagers et al., 2002; Vassi-
lopoulos et al., 2003). While some have regarded BM-derived
progenitors as pluripotent (Krause et al., 2001), including rodent
studies demonstrating the potential for these cells to give rise to
adipocytes (Majka et al., 2012; Sera et al., 2009), numerous re-
ports have demonstrated that these cells cannot differentiate
into non-hematopoietic lineages (Alvarez-Dolado et al., 2003;
Anderson et al., 2001; Berry and Rodeheffer, 2013; Johansson
et al., 2008; Wang et al., 2003; Vassilopoulos et al., 2003; Wei-
mann et al., 2003). Instead, the observation that hematopoietic
cells can fuse with recipient cells has led to the suggestion
that the resulting heterokaryons account for the presence of
donor-derived DNA in different non-hematopoietic cell types.
Despite significant efforts, it has been extremely difficult tor Inc.
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Figure 1. Selection Process of Individuals Included in the Study
Details on the inclusion criteria are described in the Experimental Procedures.
Table 1. Clinical Characteristics of the Cohort
Measure Mean (Range)
Age at transplantation (years) 33 (2–65)
Age at examination (years) 48 (19–72)
Follow-up time (years) 15 (3–31)
Donor age (years) 31 (5–67)
Body mass index (kg/m2) 25 (17–38)
Fat cell volume (picoliters, pl) 633 (232–1,139)experimentally rule out each of these possibilities (Anderson
et al., 2001), and data in different animal models have not been
able to provide any firm conclusions.
We set out to determine whether BM-derived cells may
contribute to adipogenesis in human WAT. Unfortunately, there
are currently no available experimental techniques to track the
specific origins of adipocytes in humans. We therefore investi-
gated subcutaneous WAT from patients who had undergone
allogeneic transplantation with either whole BM or mobilized
peripheral blood stem cells (PBSCs). By taking advantage of
genomic differences inherent to donor and recipient cells and
performing both bulk and single-cell analyses, we determined
the contribution of donor cells to recipient adipose tissue.
RESULTS AND DISCUSSION
Identification and Selection of Study Participants
We were able to track all subjects at our hospital who had suc-
cessfully undergone transplantations with BM or PBSCs due to
hematologic malignancies. In total, 198 subjects fulfilled the
pre-specified inclusion criteria, and the selection process is
detailed in the Experimental Procedures and in Figure 1. Forty-
four of the subjects were excluded for various reasons. Out of
the 154 subjects who were invited to take part in the study, 65Cell Meindividuals (21 women and 44 men, clinical data in Table 1)
were finally included, all of whom were relapse-free and healthy
at the time of examination. The subjects were 2–65 years old at
the time of transplantation and were recruited 3–31 years after
the procedure. This allowed us to study the contribution of
BM/PBSCs to human adipogenesis over almost the entire hu-
man lifespan, in contrast to the considerably shorter (also in rela-
tive terms) time periods used in rodent models (Crossno et al.,
2006; Koh et al., 2007; Majka et al., 2010; Sera et al., 2009; To-
miyama et al., 2008). The cohort displayed a distribution of
non-obese (n = 54) and obese (n = 11) individuals equivalent to
that of the general Swedish population (Elo and Karlberg, 2010).
Determination of Donor Contribution to the
Subcutaneous Fat Cell Population
All transplanted subjects had received donor cells that could
be readily distinguished from recipient cells by specific polymor-
phic DNA sequences. These techniques are commonly used
post-transplantation to monitor engraftment and predict the
risk of rejection and relapse (Mattsson et al., 2001). The contri-
bution of BM/PBSC-derived cells to either unfractionated WAT
or isolated adipocytes was determined by analyzing bulk popu-
lations of cells obtained by fine needle biopsy of subcutaneous
abdominal WAT. Purified fractions of adipocytes were generated
by collagenase treatment (Rodbell, 1964). We have previously
shown that this method yields an adipocyte fraction of >
99.9% purity, with no significant contamination by leukocytes
or other non-adipocytes (Spalding et al., 2008), which was
confirmed by qPCR for different cell type markers as well as
immunofluorescence (Figures S1–S2 and Supplemental Experi-
mental Procedures).
The percentage of donor cells in both unfractionated WAT
(which also includes blood cells present in capillaries) and purified
adipocytes was determined using two independent methods to
assess either microsatellite and/or single-nucleotide polymor-
phisms (SNPs) (Alizadeh et al., 2002; Lion, 2003). As expected,
the ratio of donor/recipient cells was considerable in unfractio-
nated WAT (26% ± 8.9%, mean ± SD, range 6%–51%), presum-
ably due to the presence of leukocytes (Figure 2A). The purified
adipocytes also contained a significant, albeit much lower, pro-
portion of donor-derived cells (4.8% ± 4.4%, mean ± SD, range
0.1%–27%) (Figure 2A). The percentage of donor-derived adipo-
cytes was positively correlated with time since transplantation
(Figure2B). Although the fractionof donor cells tended tobenega-
tively associated with age at transplantation (r = 0.22, p = 0.07),
this relationship became clearly non-significant (partial r = 0.08,
p = 0.58) when adjusting for time since transplantation. Further-
more, correction for different transplantation-related factors didtabolism 22, 408–417, September 1, 2015 ª2015 Elsevier Inc. 409
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Figure 2. Contribution of Bone Marrow to the Mature Adipocyte
Population and Influence of Body Weight
(A) The proportion of donor cells in recipient adipose tissue and isolated fat
cells was determined by two independent methods, as described in detail in
the Experimental Procedures. The quantitative results were based on the
mean value of at least two different polymorphic markers. The percentage of
donor-derived cells was considerable in adipose tissue pieces, presumably
due to leukocytes present in the capillaries. The donor cell fraction in isolated
adipocytes was clearly detectable, although significantly lower (by paired
t test).
(B) The proportion of donor cells in isolated adipocytes from each subject
was related to time since transplantation by linear regression analysis. The
regression line for the whole cohort is shown. When dividing the subjects into
obese (n = 11, white circles) and non-obese (n = 54, black circles), the
regression lines differed significantly (F = 13.3, p = 0.0006 by ANCOVA), but
there was no interaction between obesity status and time since transplantation
(F = 1.2, p = 0.28).
(C) The ratio of donor cells was significantly higher in the obese group
compared with non-obese subjects as calculated by unpaired t test. See also
Figures S1 and S2 and Table S1. Error bars in (A) and (C) are SEM.
410 Cell Metabolism 22, 408–417, September 1, 2015 ª2015 Elsevienot influence the correlation between time since transplantation
and donor cell infiltration (Table S1). The percentage of donor
cells in the 11 obese individuals was significantly higher than in
the non-obese subjects, both when time after transplantation
was considered (Figure 2B) and when analyzed at the group level
(Figure 2C).
The increased proportion of donor adipocytes over time in
healthy recipients, without any ongoing immunosuppressive
treatment, suggests that the contribution of BM/PBSC-derived
progenitors to adipogenesis continues throughout life and is
neither an artifact due to DNA contamination nor a transient pro-
cess due to a disrupted BM environment following the initial
treatment period. If the latter had been true, the fraction of donor
cells would have been inversely instead of positively correlated
with years following transplantation. In addition, the data indi-
cate that WAT mass influences donor cell infiltration.
We also assessed whether the proportion of donor-derived fat
cells could be predicted by the fraction of donor cells present in
the stromal vascular fraction (SVF). Because the number of cells
in the SVF was too low for cell sorting, we estimated the contri-
bution of donor cells to the SVF by subtracting the percentage of
donor cells in isolated fat cells from that of intact WAT, which we
consider as a rough proxy for donor cell infiltration into SVF.
There was no correlation between this estimate and the percent-
age of donor-derived adipocytes (Figure S2J). Moreover, the
time-dependent increase in donor-derived cells was specific
for adipocytes, as there was no association between years
post-transplantation and the estimated proportion of donor-
derived cells in the SVF (Figure S2K).
Mathematical Modeling of Donor Cell Contribution to
Adipogenesis
Theoretically, BM/PBSC-derived adipocytes will progressively
replace dying fat cells so that the proportion of donor cells in-
creases up to a steady state, corresponding to the actual contri-
bution of BM/PBSCs to the adipocyte population. To estimate
this contribution under steady-state conditions, we constructed
a mathematical model (Figure 3 and Supplemental Experimental
Procedures). Based on our previous results on adipocyte turn-
over determined using a 14C-based technique (Spalding et al.,
2008), we assumed that all adipocytes were replaced at the
same rate and calculated the fraction of BM/PBSC-derived cell
production rate required to match the observed data. With a
globally fitted adipocyte turnover rate of 6.3% per year, the
average contribution of BM/PBSCs toWATwas 9.6%, indicating
that although significant, BM/PBSCs are not the major contribu-
tors to adipogenesis. There was, however, a large inter-individ-
ual variation (9.6% ± 8.1%, mean ± SD, range 0.21%–41%),
with several subjects displayingR 20% BM/PBSC-derived cell
contribution. These estimates were independent of age at trans-
plantation, age at examination, time since transplantation,
gender (Figures S3A–S3D), fat cell volume (p = 0.22, graph not
shown), or adipose morphology (i.e., whether the average fat
cell size was relatively large or small, Figures S3E–S3G). The
average turnover rate of BM/PBSC-derived adipocytes calcu-
lated herein is close to that previously reported for human
adipocytes (8.4%), determined using an entirely different tech-
nique, i.e., 14C-dating of adipocyte DNA. The latter is a method
that is very robust against contamination of non-adipocyte cellsr Inc.
Figure 3. Mathematical Modeling of BM
Contribution to Human Adipogenesis
(A) Adipocyte death is matched by integration
of newly produced adipocytes in the WAT. Under
steady state, the turnover rate r, i.e., the rate
at which adipocytes are replaced per year, is con-
stant. BM/PBSC transplant-derived cells con-
tribute PTx cells/year toWAT, out of a total of P new
cells/year. The presence of BM/PBSC transplant-
derived adipocytes in the WAT reflects the balance
between integration of new cells in the tissue and
physiological turnover.
(B) The proportion f of transplant-derived cells
in WAT increases from zero, at the time of
transplantation, to reach an equilibrium p = PTx/P,
after a time determined by the inverse of the
turnover rate (1/r, in years). Pre-transplantation
BM-derived adipocytes will be gradually replaced by transplant-derived adipocytes. Under steady-state assumption, the proportion of transplant-derived
adipocytes at time t after transplantation is:
fðtÞ=p1 ert
Therefore, the contribution of transplant-derived cells to adipogenesis is given by the observed proportion of cells in WAT corrected by a factor depending on the
time elapsed since transplantation:
p=
fðtÞ
1 ert
See also Supplemental Experimental Procedures for more details.(up to at least 20%, see Supplemental Experimental Proce-
dures, Figures S3H and S3I, and Spalding et al., 2008). This
confirms that there is indeed a high turnover of human fat cells
in WAT.
Donor Cell Contribution Is Increased in Obesity
Using themodeled data, we estimated BM/PBSC contribution at
different levels of body mass index (BMI), an indirect measure of
body fat. A marked influence of BMI was observed where BM/
PBSC contribution to the adipocyte population was 2.5 times
higher in severely obese compared to lean individuals (Figure 4A).
In addition, there was a linear correlation between BMI and BM/
PBSC contribution (Figure 4B). This was independent of all trans-
plantation-related factors examined, with the exception of the
source of transplanted material (Table 2), where PBSC-trans-
planted subjects displayed significantly higher production rates
than recipients who had received BM (Figure 4C). These results
suggest that, at least in transplanted subjects, the increased
need of adipocyte precursors in obesity (to allow for the acceler-
ated production rate) can to a certain extent be met by BM/
PBSC-derived progenitor cells. This hypothesis is in line with
previously published data demonstrating that adipocyte progen-
itors in the SVF of obese humans display less differentiation ca-
pacity compared with non-obese individuals (van Harmelen
et al., 2003).
An obvious question raised by these results concerns the
identity of the BM/PBSC progenitor responsible for generating
adipocytes. Although the specific BM/PBSC-derived cell type
that harbors adipogenic activity is not clear, likely candidates
include the mesenchymal stem cells, which are well established
to be able to differentiate into adipocytes in vitro and are pre-
sent in the BM (Pittenger et al., 1999). However, it remains
controversial whether such cells are present to any significant
degree in the mobilized blood of healthy subjects (Ferna´ndezCell Meet al., 1997; Kassis et al., 2006; Wexler et al., 2003). The obser-
vation that PBSC-transplanted subjects displayed higher
production rates than BM recipients suggests that other pro-
genitor cells in BM/PBSC may also contribute to peripheral
adipogenesis. Possible additional cell sources could be endo-
thelial cells, as recently discussed (Gupta et al., 2012; Tran
et al., 2012).
Single-Cell Exome and Whole-Genome Sequencing
To establish whether the presence of donor-derived DNA in
recipient fat cells could be due to differentiation or cell fusion,
we developed a technique to directly assess the genotype of
single adipocytes (for details, see Supplemental Experimental
Procedures). Purified adipocyte fractions from three BM- or
PBSC-transplanted recipients were embedded in agarose and
mounted on membranes used for laser capture microdissection
(LCM) (Figure 5A). Single adipocytes were subsequently iso-
lated, and genomic DNA (gDNA) from each cell was subjected
to whole-genome amplification (WGA). Next, sequence libraries
were prepared followed by exome capture and massive parallel
sequencing of samples from single adipocytes and whole-blood
gDNA isolated from both the donor and the recipient. To distin-
guish between donor and recipient DNA, homozygous SNPs
unique for either donor or recipient were initially identified by
comparing exome sequences of whole-blood gDNA. These po-
sitions were then called in the single-cell exome data (where sig-
nals above the defined threshold could be detected) as either
donor, recipient, or mixed genotypes (Figure 5B and Figures
S4 and S5). As shown in Table S2 and Figure S4, only samples
displaying five or more variants passing the filters were included
in the analysis. In study subject 1 and 2, data from 27 and 24
cells, respectively, fulfilled this criterion, while in study subject
3, data from only 15 cells passed the filters. Consistent with
the findings from the bulk adipocyte analysis, the majoritytabolism 22, 408–417, September 1, 2015 ª2015 Elsevier Inc. 411
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Figure 4. Contribution of Bone Marrow to the Mature Adipocyte
Population and Influence of Body Weight
(A) The contribution of donor cells to the adipocyte population under steady-
state conditions (donor cell production rate) was determined using the math-
ematical model described in Figure 3. This ratio was strongly influenced by
BMI, with a proportional increase in donor adipocytes in individuals of higher
weight classes as determined by analysis of variance (p = 0.004). Results from
post hoc tests are indicated by brackets (*p < 0.05, **p < 0.01), and the number
of subjects in each weight class is indicated.
(B) There was a statistically significant relationship between BMI and donor cell
production rate as determined by linear regression analysis (n = 65).
(C) The donor cell production rate was higher in subjects who had received
PBSC compared with BM (by unpaired t test). Error bars in panels are
SEM. Regression coefficients and p values are indicated. See also Figures
S3A–S3G.
Table 2. Correlation between BMI and Donor Cell Production
Rate Corrected for Different Variables
Cofactor
Cofactor
Donor Cell
Production Rate
and BMI
F value or b
coefficient p value
F value or b
coefficient p value
Age at Tx 0.0063 0.96 0.44 0.0003
Age at biopsy 0.13 0.25 0.45 0.0002
Time after Tx 0.22 0.05 0.44 0.0002
Donor age 0.11 0.36 0.45 0.0002
Gender 0.76 0.39 15.8 0.0002
Donor gender 0.025 0.88 14.0 0.0004
Family relation 0.32 0.57 15.3 0.0002
Type of transplantation
(BM or PBSC)
4.3 0.043 13.9 0.0004
Irradiation prior to
transplantation or not
0.09 0.77 14.7 0.0003
Graft versus host
reaction, anya
0.19 0.66 15.2 0.0002
Conditioning regimen
(myeloablative/non-
myeloablative)
0.49 0.49 14.7 0.0003
Nucleated cell dose 0.22 0.05 0.47 <0.0001
Adipose tissue CD45
expression at time
of biopsy
0.00024 1.0 0.44 0.017
Fat cell volume
(picoliters, pl)
0.0011 0.99 0.37 0.0096
The influence of a number of variables on the relationship between BMI
and donor cell production rate in Figure 4B was determined by ANCOVA
and multiple regression analysis. Except for type of transplantation, no
statistically significant interaction was observed for any of the variables.
Standardized b coefficients or F values are given for continuous or nom-
inal variables, respectively.
aThere was also no effect if this co-factor was subdivided into mild or se-
vere graft versus host reaction.(90%) of the adipocytes contained SNPs representing patient-
derived DNA. Two cells, #4 from study subject 1 and #10
from study subject 2, displayed a single donor-derived variant412 Cell Metabolism 22, 408–417, September 1, 2015 ª2015 Elseviewhile otherwise displaying entirely recipient-derived genotypes
(90.9% of 11 variants and 97.8% of 45 variants, respectively)
(Figure S4). As explained in the Supplemental Experimental Pro-
cedures, these rare and unexpected donor genotypes may be
the result of artifacts arising from sample preparation and/or
erroneous genotype calls in the data analysis. From study sub-
ject 3, all analyzed cells displayed recipient-specific genotypes
(Figure S4). Cell #10 in study subject 1 displayed mixed geno-
types from both the donor and the recipient (based on a total
of 42 variants) (Figure 5B and Figure S4). This is consistent
with previous studies demonstrating cell fusion between
BM-derived cells and other non-hematopoietic cell types. Simi-
larly, in study subject 2, one cell (#11) contained both donor
and recipient variants, which could indicate a cell fusion event
(Figure S4). However, this cell displayed only five variants and
thus only weakly passed the filters established for classifying
whether a cell is of donor, recipient, or mixed origin. Data
interpretation for this cell must therefore be considered less
confident than for cell #10 from study subject 1. Two adipocytesr Inc.
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Figure 5. Laser Capture Microdissection,
Exome Sequencing, and Whole-Genome
Sequencing of Single Adipocytes Isolated
from Study Subject 1
(A) Representative photomicrographs of individual
mature fat cells isolated from study subject 1 prior
to capture. Triglycerides were stained with BODIPY
and nuclei with Hoescht. Cells were isolated using
laser capture microdissection, their genomes
amplified using whole-genome amplification, and
exomes and genomes were sequenced in order to
determine their genotypes. The individual cells are
cell #2, cell #10, and cell #16, and their corre-
sponding genotypes, determined by exome and
whole-genome sequencing, are shown in (B) and
(C), respectively. Scale bar is 100 mm.
(B) Exome-wide distribution of donor- and recip-
ient-specific homozygous SNPs in single adipo-
cytes isolated from study subject 1. Only samples
with five or more variants passing the filters were
included. Each row represents a sample, and each
column represents a SNP position; the top two
rows represent donor (pink) and recipient (blue)
whole-blood gDNA while the rows below represent
analyses of gDNA from single cells. All homozygous
SNPs that differ between the donor and recipient
and from which at least one single cell displays a
signal above the defined threshold are depicted.
Each detected SNP in the single cells has
been assigned a color depending on whether the
genotype at that position corresponds to the
donor (pink), the recipient (blue), or both (yellow).
Positions where no signals above the defined
thresholds were detected are depicted in gray. Out of 27 analyzed cells from this subject, cell #10 displayed mixed genotypes, cell #16 displayed donor-specific
genotypes, and the remaining cells, represented here by cell #2, displayed recipient-specific genotypes. Further descriptions are found in the Supplemental
Information and Figures S4 and S5.
(C) The classification of cell origin of cell #2, cell #10, and cell #16 determined by exome sequencing was confirmed by whole-genome sequencing. Circle plots
detail the number of detected donor, recipient, and mixed variants across the entire genome identified in these three cells.(morphologically indistinguishable from recipient-derived fat
cells), #16 fromstudy subject 1 (Figures 5A and 5BandFigure S4)
and #24 from study subject 2 (Figure S4), harbored donor-spe-
cific genotypes, indicating that circulating BM/PBSC-derived
progenitor cells can differentiate into adipocytes in humans.
Finally, we selected three previously exome-sequenced samples
from donor 1 for whole-genome sequencing, which included one
recipient-derived cell (cell #2), the donor-derived cell (cell #16),
and the cell of mixed origin (cell #10) (Figure 5C). This allowed
us to analyze recipient- and donor-specific variants across the
entire genome and confirmed the conclusions drawn from
exome sequencing regarding the origins of these cells. Thus,
both exome and whole-genome sequencing at the single-cell
level suggest that, in transplanted subjects, BM/PBSC-derived
progenitors incorporate into WAT via at least two possible and
separate mechanisms, namely adipocyte differentiation or cell
fusion. Admittedly, we have no direct proof for either process,
as this would require us to follow the fate of single cells in vivo,
techniques that are clearly not available for studies in man.
Our single-cell results are based on data obtained from a
limited number of adipocytes from three re-investigated individ-
uals. It should be pointed out that isolation ofmature fat cells pre-
sents particular difficulties, as they float in suspension and do not
stick to a cell plate surface. These circumstances preclude high-
throughput/automated investigations, and the manual workCell Merequired for LCM is very time-consuming. Nevertheless, the
proportion of cells displaying donor-derived sequences was
comparable to that observed in bulk preparations of mature fat
cells (i.e., 5%). The single-cell preparation did not allow simul-
taneous isolation of DNA and RNA, and to our knowledge it is not
yet possible to isolate the amounts of both RNA and DNA from
single cells required to obtain sufficiently informative results.
Consequently, we were unable to determine gene expression,
although all isolated cells displayed the classic morphologic
characteristics of mature fat cells (i.e., spherical shape, large
diameter, a single large triglyceride droplet constituting > 90%
of the volume, and the presence of a single nucleus). Still, tran-
scriptional profiling of single adipocytes would be very relevant,
as murine data suggest that BM-derived fat cells display a
different phenotype compared with adipocytes derived from
endogenous progenitors (Majka et al., 2010).
Although donor-recipient cell fusion is generally accepted to
occur in both humans and rodent models, the significance of
this process is less well understood. Furthermore, it is not known
whether the fused cells retain the full DNA content of both the
donor and recipient cells or undergo reduction divisions to
restore diploidy. This is particularly interesting for post-mitotic
cells such as mature adipocytes. However, due to technical lim-
itations in single-cell sequencing assays, this issue remains diffi-
cult to determine at present.tabolism 22, 408–417, September 1, 2015 ª2015 Elsevier Inc. 413
Donor Cell Contribution in Relation to Inflammation and
Fat Cell Volume
Murine studies have found an increase in cell fusion induced
by irradiation-induced inflammation (Johansson et al., 2008).
We did not observe any effect of transplantation-related treat-
ment variables, including prior irradiation or graft-versus-host
reactions, on the infiltration rate of donor adipocytes (measured
either as production ratio or percentage infiltration) (Table 2 and
Table S1). Moreover, donor cell infiltration was not influenced
by the expression of the pan-leukocyte marker CD45 in the adi-
pose biopsies (Table 2 and Table S1). BM/PBSC transplantation
is indeed a unique setting where subclinical inflammation can
manifest in a variety of tissues, which may potentially contribute
to cell fusion events. However, this could hardly explain the
fact that we were able to identify adipocytes that are most likely
derived from a donor BM/PBSC, as evidenced by a > 98%
donor-specific SNP call profile. Together, these results speak
against systemic and/or local inflammation as an important
factor influencing our findings. Nevertheless, given recent data
in mouse models suggesting that inflammation impacts posi-
tively on WAT remodeling (Wernstedt Asterholm et al., 2014),
we cannot exclude that a low grade-inflammation per se
may promote the increased donor cell contribution in obesity,
e.g., by release of factors influencing proliferation and/or
differentiation.
Variations in adipocyte volume in the bulk-prepared adipo-
cytes did not impact on the associations between time since
transplantation and donor cell percentage (Table S1) or BMI
and donor cell production rate (Table 2 and Figures S3E–S3G).
Furthermore, at the single-cell level, the diameters of the
donor/mixed cells were found to be on either side of the distribu-
tion spectrum (Figures S5D and S5E). Thus, there was no
obvious difference in size between adipocytes with different ge-
notypes. Although hypothetical, a possible interpretation of
these observations is that donor-derived fat cell progenitors un-
dergo a normal adipogenic program.
The present data are solely based on subcutaneous WAT.
Given results in mice demonstrating that visceral WAT displays
more pronounced infiltration rates than subcutaneous WAT
(Majka et al., 2010), it would be interesting to study this depot
in man. For obvious ethical reasons, it was not possible to obtain
visceral WAT samples from the individuals included in the pre-
sent study.
In summary, our results suggest that in transplanted subjects
followed for up to several decades, BM/PBSC-derived circu-
lating progenitor cells contribute to human adipogenesis. This
is particularly evident in individuals with excess adipose tissue
and occurs, at least in part, by differentiation of single precursors
into adipocytes, indicating that human BM may serve as a re-
servoir for adipocyte progenitors. Although the circumstances
following BM transplantation are different from those in the
healthy physiological state, it could be hypothesized that BM-
derived progenitors may contribute to the subcutaneous fat
cell population also under normal conditions. Whether this
is true remains to be shown and requires the development of
novel techniques to determine cellular origin in man. Neverthe-
less, if our data can be reproduced in non-transplanted subjects,
it could have an impact on BM-directed approaches to treat hu-
man metabolic disorders.414 Cell Metabolism 22, 408–417, September 1, 2015 ª2015 ElsevieEXPERIMENTAL PROCEDURES
Subjects and Clinical Assessments
Thanks to the compulsory use of unique personal security numbers and
computerized health care records in Sweden, we were able to track every
living subject who had successfully undergone transplantations with BM or
PBSCs due to hematologic malignancies at our hospital since 1975. We iden-
tified 198 subjects who fulfilled the following inclusion criteria: no sign of leuko-
cyte chimerism (i.e., their blood cells were entirely donor derived), time from
transplantation R 2.5 years, otherwise healthy and living within a four-hour
range (by car or train) from our hospital, or still attending controls at our unit
despite living further away. Forty-four of the 198 subjects were excluded for
various reasons, predominantly because the subjects had moved abroad or
because current contact details were lacking. A total of 154 subjects were
invited by letter to take part in the study; 47 declined and 26 subjects did
not respond despite reminders. Eighty-one individuals were scheduled for
inclusion, but 16 were for different reasons not eligible, resulting in the final
inclusion of 65 individuals. Reasons for exclusion included other concomitant
diseases/conditions or that the subjects withdrew their informed consent.
Forty-three subjects had received whole BM, while 22 were transplanted
with PBSCs. Six patients received a non-myeloablative conditioning with
busulfan + fludarabine. The rest of the patients had a myeloablative condition-
ing regimen with cyclophosphamide in combination with either total body irra-
diation (n = 40) or busulfan (n = 19). Antithymocyte globulin was used as part of
the conditioning regimen in all patients with unrelated donors (n = 17) and in
one patient with a sibling transplant. As graft-versus-host prophylaxis, most
patients had received a combination of methotrexate and cyclosporine A
(n = 48), while some had a monotherapy with either methotrexate (n = 9) or
cyclosporine A (n = 4). Details regarding the transplant procedure are pub-
lished elsewhere (Uzunel et al., 2006). Abdominal subcutaneous WAT was
obtained by fine needle biopsy under local anesthesia the morning after an
overnight fast. Venous blood samples were taken from the brachiocephalic
vein. Body mass index was calculated as the weight in kilograms divided by
the square of the height in meters and used to categorize subjects in different
weight classes: lean (< 25 kg/m2), overweight (R 25 and < 30 kg/m2), obese (R
30 and < 35 kg/m2), and severely obese (R 35 kg/m2). Body composition and
total fat mass was measured by bioimpedance using TANITA Body Fat
Analyzer TBF-305 (TANITA Europe BV) and Bodystat Quad Scand 4000 (Body-
Stat Ltd.). The mean values of these two measurements were used. Ethical
permission was granted from the regional ethics committee, Stockholm, Swe-
den, and all studies were performed in accordance with the Declaration of
Helsinki. The study was explained in detail to each participant and informed
written consent was obtained.
Fat Cell Isolation and Purity Assessments in Isolated Adipocytes
Isolated fat cells were prepared from WAT biopsies by the Rodbell method
(Rodbell, 1964). In brief, adipose tissue pieces were washed and dissected
(to remove blood and visible blood vessels), followed by digestion in Krebs-
Ringer-phosphate buffer (KRP) containing 100 U/ml collagenase and 4%albu-
min for 60 min at 37C in a shaking water bath. Any remaining undigested
tissue was removed by filtration. The floating adipocytes were washed three
times with KRP containing 0.1% albumin. The cell volume was calculated
from the diameter using a described formula (Arner et al., 2013). Details on
the methods used to determine any possible contamination of non-adipose
cells in purified adipocytes are described in the Supplemental Experimental
Procedures.
Determination of Adipose Tissue Morphology
Details on the determination of adipose tissue morphology are given in the
Supplemental Experimental Procedures.
Assessment of Donor Cell Ratio in WAT and Adipocytes
The proportion of donor cells in bulk analyses of WAT and isolated adipocytes
was determined with two independent quantitative PCR methods based
on either microsatellites (STR, short tandem repeats) and/or SNPmarkers. Mi-
crosatellite analysis was performed in most patients since this method gives
more accurate quantitative results. With fluorescent primers, different micro-
satellites were amplified and the PCR products were analyzed with capillaryr Inc.
electrophoresis (3130 genetic analyzer, Applied Biosystems). The area of the
peaks (PCR products) of the patient and the donor samples were used to
quantify the fraction of donor cell contribution (Winiarski et al., 1998). SNP
analysis was performed with real-time PCR and used as a complement to
the microsatellite method when the level of donor cell contribution was low
(< 2%). The primers and probes used for SNP analysis were adopted from Ali-
zadeh et al. (2002). In short, biallelic genetic markers were used to screen pre-
transplant patient and donor DNA samples. An allele was informative when it
was positive for patient DNA and negative for donor DNA. Detection and quan-
tification was performed on the ABI 7500 SequenceDetection System (Applied
Biosystems) using TaqMan technology. The amount of amplifiable DNA in
each sample was assessed by parallel amplification of the reference gene
GAPDH (glyceraldehyde phosphate dehydrogenase). All samples were run in
duplicate, and the pre-transplantation patient and donor DNA samples were
included in each run. Relative quantification of recipient DNA was calculated
according to the DDCt method (Applied Biosystems, user bulletin 2) using
GAPDH as a reference gene and the pre-SCT patient sample as a calibrator.
The formula used was 2(DCtU  DCtC), where DCt = Ct target gene  Ct refer-
ence gene, U is the unknown sample, and C is the calibrator sample. The final
quantitative results of donor cell percentage were calculated as mean values
of at least two different microsatellites and/or SNP markers.
Modeling BM Contribution to Adipogenesis
Details on the mathematical modeling are given in the Supplemental
Information.
Sample Preparation and LCM of Single Adipocytes
Because of the cumbersome technique necessary to isolate single cells, it
was not possible to perform these investigations in connection with the first
visit to our clinical research facility. Instead, after obtaining data on donor cell
infiltration rates from the bulk analyses, nine subjects with mean infiltration
rates of 10% and living in the Stockholm area were asked to come back
for additional analyses. Three subjects underwent fine needle biopsies of
subcutaneous abdominal WAT as described above. One hundred microliters
from a pure adipocyte fraction was suspended in 1,000 ml of sterile PBS (Life
Technologies). Adipocytes were stained with Hoechst 33342 (1:1,000 dilu-
tion, Invitrogen) for detection of nuclei and BODIPY (1:2,000 dilution, Invitro-
gen) for detection of lipid content for 20 min at room temperature in the dark.
In order to isolate individual adipocytes, a 1% agarose gel was prepared by
mixing 20 mg of low-temperature gelling agarose (Sigma Aldrich) with 2 ml of
PBS (Life Technologies) and heated in a 100C water bath until it dissolved
into solution. The gel was then allowed to cool to approximately 30C (the gel
solidifies at 24C–28C), and equal amounts of cell suspension and 1%
agarose gel mixture were mixed to a final concentration of 0.5% agarose.
From the agarose cell suspension, 100 ml was smeared onto frame slides
(Leica). The agarose-embedded adipocytes were microscopically identified
based on lipid content and the presence of a nucleus (enabling the distinc-
tion between fat droplets and adipocytes). Single adipocytes were isolated
by LCM using a Leica LMD 7000 system and transferred into the cap of a
microcentrifuge tube used for buffer-free sample capture (AdhesiveCap
200, ZEISS). Photomicrographs were obtained of all single cells included in
the study, before and after LCM. Representative photomicrographs are pre-
sented for three single cells isolated from study subject 1, prior to capture
(Figure 5A) and following capture and detection in the caps of separate mi-
crocentrifuge tubes (Figure S5F). Images were processed and background
compensation was performed using ImageJ. All cells contained a single
intracellular nucleus, and there were no signs of contamination by non-
adipocyte cells in the cell preparations. Because the average proportion of
donor cells in isolated adipocytes was 5%, we processed R 30 cells
from each subject in order to ensure statistically that at least one would
contain DNA from the donor. Captured single adipocytes were stored in
the cap of microtubes and placed in an upside-down position at 80C prior
to further analyses.
WGA of Single Adipocytes
DNA of single cells was amplified using Pico Plex WGA kit (Rubicon Geno-
mics) according to the protocol provided by the manufacturer. Two modifi-
cations were made to the protocol: cell extraction buffer was applied in aCell Memixture with extraction enzyme dilution buffer and cell extraction enzyme.
Reagents were added into the caps of the tubes containing the captured
adipocytes, and the lysis reaction was performed with the tubes positioned
upside down in a sterile 24-well plastic dish positioned on a heating block
set to 75C for 10 min followed by 95C for 4 min. To maintain constant
temperature during the process and prevent evaporation, a pre-heated
metal block was placed on top of the plates throughout the incubation. Af-
ter lysis incubation, the reaction was collected in the bottom of the tube by
centrifugation. All remaining reagents were added to the reaction with the
tube in an upright position. Following amplification, the WGA product was
purified using Zymo DNA clean and concentrator columns according to
the protocol provided by the manufacturer (Zymo Research). DNA integrity
was validated using a 2100 Bioanalyzer (Agilent) with the DNA 1000 chips
and reagents (Agilent) (Figure S5A). DNA was stored at 20C until further
processing.
Library Preparation, Exome Enrichment, and Exome and
Whole-Genome Sequencing
Illumina sequencing libraries were prepared fromwhole-genome amplified sin-
gle cells and gDNA extracted from whole blood from the three recipient and
donor pairs using a previously described automated protocol (Borgstro¨m
et al., 2011), modified to be compatible with Illumina TruSeq library preparation
protocols and reagents. Due to the small fragment sizes of 250–350 bp gener-
ated by WGA (Figure S5A), the size selection step was omitted for the single-
cell samples. The finished sequencing libraries were pooled to contain six
libraries in each pool. Next, Illumina TruSeq Exome Enrichment was performed
for each pool according to the manufacturer’s protocols. Sequencing of
the exome-enriched pools was performed on several runs of Illumina HiSeq
(2 3 100 bp, Rapid mode) and Illumina MiSeq (2 3 150 bp). Illumina TruSeq
Libraries from three single cells (cell #2, cell #10, and cell #16) isolated from
study subject 1 were selected for whole-genome sequencing together with
gDNA from the recipient and the donor. Whole-genome sequencing was
performed on Illumina HiSeq (2 3 100 bp, High output mode). Details on the
analyses of exome and whole-genome sequencing data are provided in the
Supplemental Experimental Procedures.
Statistical Methods
Values are, unless otherwise stated, mean ± standard error of the mean (SEM).
They were compared using paired or unpaired t test, analysis of covariance
(ANCOVA), and linear or multiple regression analysis.
ACCESSION NUMBERS
Raw sequencing data are deposited at the European Nucleotide Archive
(http://www.ebi.ac.uk/ena) under the accession number ENA: PRJEB9177.
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